Text Size

Interactive Voice Response (IVR) for Methadone Patients

This study has been completed.
Sponsor:
Information provided by:
Butler Hospital
ClinicalTrials.gov Identifier:
NCT00237406
First received: October 11, 2005
Last updated: March 24, 2010
Last verified: March 2010
History of Changes
  Purpose

This study is designed to test whether a telephone call-in program is a feasible way to collect mood and drug-related information in individuals enrolled in a methadone maintenance program.


Condition Intervention Phase
Opioid-Related Disorders
 Procedure: interactive voice response
 Phase 3

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Interactive Voice Response for Methadone Patients

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Butler Hospital:

Estimated Enrollment: 50
Study Start Date: January 2006
Study Completion Date: October 2006
Detailed Description:

Participants will complete a baseline interview and a follow-up interview at 5-weeks post-baseline. Two-thirds of the participants will be randomized into the telephone call-in group, and will be asked to complete daily, 10-minute, telephone interviews. To complete these interviews, participants will call into a toll-free telephone interview system with a unique and private Study ID number, and answers questions by using the telephone key pad. Questions during both the face-to-face interviews and the telephone interviews will assess mood, sleep, treatment utilization and drug-related experiences. Participants will be compensated for their time.

Comparison(s): Participants randomized into the telephone component of the study as compared to participants in the interview-only component of the study.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Individuals who recently enrolled in methadone maintenance for opioid addiction.

Criteria

Inclusion Criteria:

  • Recent enrollment in a methadone maintenance program

Exclusion Criteria:

  • Enrollment in a methadone maintenance program within the prior 3 months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00237406

Locations
United States, Rhode Island
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Butler Hospital
Investigators
Principal Investigator: Michael D Stein, MD Rhode Island Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00237406     History of Changes
Other Study ID Numbers: 4065-05
Study First Received: October 11, 2005
Last Updated: March 24, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Butler Hospital:
IVR, methadone
methadone maintenance

Additional relevant MeSH terms:
Opioid-Related Disorders
Substance-Related Disorders
Mental Disorders
Methadone
Analgesics, Opioid
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
 Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
Central Nervous System Depressants
Antitussive Agents
Respiratory System Agents
Narcotics

ClinicalTrials.gov processed this record on June 18, 2013